Study for the effects of oral semaglutide on glycemic control in patients with type 2 diabetes
Phase 4
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000045270
- Lead Sponsor
- Hokkaido University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 172
Inclusion Criteria
Not provided
Exclusion Criteria
1) patients with type 2 diabetes who were treated with any GLP-1 receptor agonist 2) history of anaphylaxis of semaglutide 3) unstable retinopathy 4) severe hepatic dysfunction or renal dysfunction 5) severe ketosis, diabetic coma 6) severe infection, surgery, serious trauma 7) pregnancy 8) patients who are inadequate to enter this study due to the other reasons by physician's judgments
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method